Cargando…

Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis

Objective. To assess the efficacy and safety profiles of two different rituximab retreatment regimens in patients with RA. Methods. Four hundred and ninety-three RA patients with an inadequate response to MTX recruited into rituximab Phase II/III studies received further courses of open-label rituxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emery, Paul, Mease, Philip J., Rubbert-Roth, Andrea, Curtis, Jeffrey R., Müller-Ladner, Ulf, Gaylis, Norman B., Williams, Sarah, Reynard, Mark, Tyrrell, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222846/ https://www.ncbi.nlm.nih.gov/pubmed/21926153 http://dx.doi.org/10.1093/rheumatology/ker253

Ejemplares similares

Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
por: Koehm, Michaela, et al.
Publicado: (2022)

Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
por: Haller, Christoph, et al.
Publicado: (2021)

Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2021)

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
por: Kekow, Joern, et al.
Publicado: (2012)

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
por: Tak, Paul P, et al.
Publicado: (2011)

Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
por: Behrens, Frank, et al.
Publicado: (2021)

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
por: Emery, P, et al.
Publicado: (2010)

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
por: Rubbert-Roth, Andrea, et al.
Publicado: (2010)

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
por: Rubbert-Roth, Andrea, et al.
Publicado: (2009)

Rituximab for the treatment of rheumatoid arthritis: an update
por: Mok, Chi Chiu
Publicado: (2013)

Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study
por: Pritchard, Charles H, et al.
Publicado: (2014)

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis
por: Arnold, Jack, et al.
Publicado: (2022)

Rituximab and its potential for the treatment of rheumatoid arthritis
por: Bryant, Adam, et al.
Publicado: (2006)

Rituximab treatment in rheumatoid arthritis: how does it work?
por: Boumans, Maria JH, et al.
Publicado: (2009)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Prevention is better than treatment
Publicado: (2015)

Is a meditation retreat the better vacation? effect of retreats and vacations on fatigue, emotional well-being, and acting with awareness
por: Blasche, Gerhard, et al.
Publicado: (2021)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Tuscano, Joseph M, et al.
Publicado: (2009)

Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19
por: Holman, Andrew J., et al.
Publicado: (2021)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Can Machine Learning Be Better than Biased Readers?
por: Hibi, Atsuhiro, et al.
Publicado: (2023)

Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis
por: Cohen, Stanley B., et al.
Publicado: (2018)

Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials
por: Moots, Robert J., et al.
Publicado: (2017)

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
por: Hainsworth, John D
Publicado: (2003)

Marked deterioration in rheumatoid arthritis associated bronchiectasis following treatment with Rituximab
por: Musameh, K., et al.
Publicado: (2019)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy, Hasan, et al.
Publicado: (2020)

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients
por: Wendler, Joerg, et al.
Publicado: (2014)

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
por: Emery, P, et al.
Publicado: (2015)

Characteristics and Treatment Outcomes of Retreatment Tuberculosis Patients in Benin
por: Ade, Serge, et al.
Publicado: (2016)

Reform in the Treatment of the Insane, with the Early History of the Retreat, York
Publicado: (1893)

p53 in rheumatoid arthritis: friend or foe?
por: Müller-Ladner , Ulf, et al.
Publicado: (2000)

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011)

Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment
por: Rehnberg, Maria, et al.
Publicado: (2010)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Rationale of using different biological therapies in rheumatoid arthritis
por: Geyer, Matthias, et al.
Publicado: (2010)

Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety
por: Mease, Philip J.
Publicado: (2011)

Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI
por: Peterfy, Charles G, et al.
Publicado: (2012)

Delayed Cerebral Ischemia: Is Prevention Better Than Treatment?
por: Koenig, Heidi M., et al.
Publicado: (2021)

Is a test better than no test when there is no treatment?
por: Downs, Louise O.
Publicado: (2023)

Diabetic foot ulcers: prevention is better than treatment
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rfb4q7boec3v0tdksv7qg8pagf